Browse News

Found 1,906 articles

• CareOne's Elizabeth Straus Named Healthcare Professional of the Year

  6/20/2019

  CareOne's Executive Vice President Elizabeth Straus, has been named NJBiz's 2019 Healthcare Professional of the Year. 

• ValGenesis Releases Next Generation Electronic Log Management Solution with Mobile Support

  6/18/2019

  ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Solutions, announced the release of its next generation Electronic Logbook.

• Golden State Killer Case Selected As 2019 DNA Hit Of The Year

  6/18/2019

  The forty-five-year investigation resulted in arrest after law enforcement's use of investigative genetic genealogy

• Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma

  6/15/2019

  Durable Responses Observed in DLBCL and Indolent Lymphoma; Median Duration of Response Not Yet Reached

• Blueprint Medicines Presents Updated EXPLORER Trial Data for Avapritinib in Patients with Systemic Mastocytosis at 24th EHA Congress

  6/15/2019

  Blueprint Medicines Corporation, announced updated data from the ongoing, registration-enabling EXPLORER trial of avapritinib in patients with systemic mastocytosis.

• Massachusetts High Technology Council Holds 2019 Annual Meeting

  6/14/2019

  Before an audience of 200 technology and civic leaders at Boston's Seaport Hotel, the Massachusetts High Technology Council honored University of Massachusetts at Lowell Chancellor Jacqueline Moloney with its Ray Stata Leadership and Innovation Award, and hosted Governor Charlie Baker and Congressman Joseph P. Kennedy, III at its 2019 Annual Meeting on June 10.

• Bristol-Myers Squibb Announces Dividend payable on August 1, 2019

  6/13/2019

  The Board of Directors of Bristol-Myers Squibb Company declared a quarterly dividend of forty one cents per share on the $.10 par value Common Stock of the corporation.

• Madison Startup Otologic Technologies Wins Life Sciences Category in the 2019 Wisconsin Governor's Business Plan Contest

  6/11/2019

  The Wisconsin Technology Council honored Madison-based health tech startup Otologic Technologies, Inc. with their top award in the Life Sciences Category of the Wisconsin Governor's Business Plan Contest on Wednesday, June 5. Otologic Technologies is developing an artificial intelligence system to help doctors better diagnose ear disease.

• Prison Needle Exchange Program - Handling Needles: Not Our Job!

  6/7/2019

  Hundreds of correctional officers delivered a giant needle to Parliament in protest of the Prison Needle Exchange Program.

• Analysis of Newly Expanded Cumulative Cohort Demonstrates that DecisionDx-Melanoma Improves Risk Prediction for Patients with Cutaneous Melanoma

  6/6/2019

  Poster presentation at 2019 Fall Clinical Dermatology Conference for PAs & NPs

• Amgen Highlights the Versatility of the BiTE® Immuno-Oncology Platform in Multiple Tumour Types at ASCO 2019

  6/5/2019

  Updated Phase 1 Data of Investigational AMG 420 in Relapsed and/or Refractory Multiple Myeloma Highlighted in Oral Presentation and Accepted for Best of ASCO®

• Question: Can you quantify the value of your workforce?

  6/5/2019

  Brookfield Asset Management and The Co-operators Group examine answers

• Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab)

  6/3/2019

  Bristol-Myers Squibb Company (NYSE: BMY) today announced updated results from studies evaluating Opdivo (nivolumab) and Yervoy (ipilimumab), alone or in combination, in patients with advanced or metastatic melanoma.

• Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials

  6/3/2019

  Primary analysis of investigational capmatinib (INC280) in the GEOMETRY mono-1 study demonstrates promising efficacy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring MET exon-14 skipping mutation

• Takeda Presents Results from Lung Portfolio Including Phase 1/2 Study of TAK-788 in a Rare Form of NSCLC and New Data on Overall Health-Related Quality of Life for ALUNBRIG® (brigatinib)

  6/3/2019

  Takeda’s Growing Lung Portfolio is Driven by a Dedication to Developing Innovative Therapies for People Living with NSCLC

• Amgen Highlights The Versatility Of The BiTE® Immuno-Oncology Platform In Multiple Tumor Types At ASCO 2019

  6/2/2019

  Updated Phase 1 Data of Investigational AMG 420 in Relapsed and/or Refractory Multiple Myeloma Highlighted in Oral Presentation and Accepted for Best of ASCO®

• Futurus Group Files First Ever Patent to Predict Gratitude Using Artificial Intelligence

  5/31/2019

  Futurus Group, an affiliate of Gobel Enterprises and a full-service consulting firm focused on artificial intelligence, announced that it is seeking a patent for its proprietary gratitude prediction machine learning model.

• Exactech Launches Its Summer Internship Program with Record-Breaking Participants

  5/30/2019

  Putting its new 67,000 square foot building and four-story parking garage to good use, Exactech, a developer and producer of bone and joint restoration products for extremities, hip, and knee, kicks off its summer internship program with a record-setting class.

• First Czech Republic Diabetic Patient with Critical Limb Ischaemia Treated with Novel Regenerative Therapy by Associate Professor Václav Procházka at University Hospital Ostrava

  5/29/2019

  Phase III SALAMANDER Trial of Rexgenero’s REX-001 Open and Recruiting

• Earnin Announces HealthAid and Cash Back Rewards, Two Products to Help Its Community Fight Financial Unfairness

  5/22/2019

  Earnin Helped People Save an Average of $100 Per Medical Bill with HealthAid and Launched a Nearly 400,000 Person Waitlist for Its Cash Back Rewards Program